Inform Genomics Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Inform Genomics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011045
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Inform Genomics Inc (Inform Genomics) manufactures and markets genomic-based personalized medicine products for cancer and supportive care. The company’s onpart is a medicinal product, which is used for the treatment of decisions in patients, who receive chemotherapy for colorectal, breast, lung, or ovarian cancer. It utilizes a proprietary analytic platform to develop genomic-based, precision medicine products. Inform Genomics’ Mucosit is a product candidate that helps physicians to identify and target only the high-risk group. The company collaborates with biopharmaceutical companies to evaluate the risk for chemotherapy-induced nausea and vomiting in patients, who receive certain moderately emetogenic chemotherapy regimens and standard antiemetic therapy. Inform Genomics is headquartered in Boston, Massachusetts, the US.

Inform Genomics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Inform Genomics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Inform Genomics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Inform Genomics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Inform Genomics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Inform Genomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Inform Genomics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Inform Genomics to Raise USD1.4 Million in Venture Financing 10
Inform Genomics Raises USD2.6 Million in Venture Financing 11
Inform Genomics Raises Additional USD0.36 Million in Venture Financing 12
Inform Genomics Raises US$1.2 Million In Venture Financing 13
Inform Genomics Inc – Key Competitors 14
Inform Genomics Inc – Key Employees 15
Inform Genomics Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Inform Genomics Inc, Medical Equipment, Key Facts 2
Inform Genomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Inform Genomics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Inform Genomics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Inform Genomics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Inform Genomics Inc, Deals By Market, 2011 to YTD 2017 8
Inform Genomics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Inform Genomics to Raise USD1.4 Million in Venture Financing 10
Inform Genomics Raises USD2.6 Million in Venture Financing 11
Inform Genomics Raises Additional USD0.36 Million in Venture Financing 12
Inform Genomics Raises US$1.2 Million In Venture Financing 13
Inform Genomics Inc, Key Competitors 14
Inform Genomics Inc, Key Employees 15
Inform Genomics Inc, Other Locations 16

★海外企業調査レポート[Inform Genomics Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Stabilis Solutions Inc (AETI):企業の財務・戦略的SWOT分析
    Summary Stabilis Solutions Inc (Stabilis Solutions) formerly, Stabilis Energy Inc a subsidiary of Amnor Technologies Inc, is a provider of power delivery solutions. The company's products comprise power distribution and power conversion products. Stabilis Solutions power distribution products compri …
  • Sc Arcada Con Srl:企業の戦略的SWOT分析
    Sc Arcada Con Srl - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Kronos Incorporated:企業の戦略・SWOT・財務分析
    Kronos Incorporated - Strategy, SWOT and Corporate Finance Report Summary Kronos Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Secom Co Ltd.:企業の戦略・SWOT・財務分析
    Secom Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary Secom Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • The Quizno’s Master LLC:企業の戦略・SWOT・財務情報
    The Quizno’s Master LLC - Strategy, SWOT and Corporate Finance Report Summary The Quizno’s Master LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • SK Hynix Inc.:企業の戦略・SWOT・財務情報
    SK Hynix Inc. - Strategy, SWOT and Corporate Finance Report Summary SK Hynix Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Burgan Bank Sak:企業の戦略・SWOT・財務分析
    Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report Summary Burgan Bank Sak - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Pelago Bioscience AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Pelago Bioscience AB (Pelago Bioscience) is a developer of patented cellular thermal shift assay for use in determination and quantification of drug–target interactions. The company utilizes patented CETSA technology which enables direct, in situ physiologically relevant measurements of targ …
  • Medpace Inc (MEDP)-製薬・医療分野:企業M&A・提携分析
    Summary Medpace Inc (Medpace), a subsidiary of Medpace Holdings Inc is a contract research organization that develops research based drug and medical device. The organization's services comprise medical affairs, regulatory affairs and medical writing, clinical monitoring, clinical trial management, …
  • Gooch & Housego PLC:企業の戦略・SWOT・財務情報
    Gooch & Housego PLC - Strategy, SWOT and Corporate Finance Report Summary Gooch & Housego PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • TransAlta Corporation (TA)-エネルギー分野:企業M&A・提携分析
    Summary TransAlta Corporation (TransAlta) is an electricity generation company. It generates electricity from a contracted portfolio of assets using diverse sources such as coal, natural gas, hydro, wind and geothermal. TransAlta's service portfolio comprises commercial and industrial energy service …
  • Nuclear Power Corporation of India Ltd-エネルギー分野:企業M&A・提携分析
    Summary Nuclear Power Corporation of India Ltd (NPCIL) designs, constructs, commissions and operates nuclear power reactors. It is controlled and governed by the Department of Atomic Energy (DAE), Government of India. The company generates power from nuclear with pressurized heavy water reactor, lig …
  • Allegra Orthopaedics Ltd (AMT)-医療機器分野:企業M&A・提携分析
    Summary Allegra Orthopaedics Ltd (Allegra), develops, manufactures and sells prosthetic implants and related orthopedic medical devices. Its major products include adult and adolescent clavicle fixation system and pin; shoulder implants; proximal humeral plates; trauma distal radial plates and syste …
  • Cooper Energy Ltd (COE):企業の財務・戦略的SWOT分析
    Summary Cooper Energy Ltd (CEL) is an oil and gas exploration and production company that offers oil production programs. The company produces, and commercializes crude oil and natural gas products. It conducts exploration for oil and gas through a portfolio of prospective acreage in the Cooper, Otw …
  • Oncolytics Biotech Inc (ONC)-製薬・医療分野:企業M&A・提携分析
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials indi …
  • Tompkins Financial Corp (TMP):企業の財務・戦略的SWOT分析
    Tompkins Financial Corp (TMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • ZIOPHARM Oncology Inc (ZIOP)-製薬・医療分野:企業M&A・提携分析
    Summary Ziopharm Oncology Inc (Ziopharm), formerly EasyWeb Inc is a biotechnology company that discovers and develops cancer therapies. The company develops novel gene expression, control and cell technologies to provides cell-based therapies for the treatment of cancer and graft-versus-host-disease …
  • Bafna Pharmaceuticals Ltd (BAFNAPHARM)-製薬・医療分野:企業M&A・提携分析
    Summary Bafna Pharmaceuticals Ltd (Bafna Pharmaceuticals) is a pharmaceutical company which manufactures and markets pharmaceutical products. The company’s operations include domestic marketing, international marketing, international export and business development. Its products comprise raricap, ra …
  • Musgrave Group Plc:戦略・SWOT・企業財務分析
    Musgrave Group Plc - Strategy, SWOT and Corporate Finance Report Summary Musgrave Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • MISC Bhd (MISC):石油・ガス:M&Aディール及び事業提携情報
    Summary MISC Bhd (MISC), a subsidiary of Petroliam Nasional Berhad (Petronas), is an international energy shipping and maritime conglomerate. The company is a fully integrated maritime, offshore floating solution, heavy engineering and logistics service provider. Its principal business activities in …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆